CYP2A6 polymorphisms in Malays, Chinese and Indians

References

• Ariyoshi N, Sawamura Y, Kamataki T. A novel single nucleotide polymorphism altering stability and activity of CYP2A6. Biochemical and Biophysical Research Communications 2001; 281: 810–814
   PubMed Web of Science ®Google Scholar
• Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Research 1979; 7: 1513–1523
   PubMed Web of Science ®Google Scholar
• Burns GW. Population genetics. In: The science of genetics: An introduction to heredity, 4th. Collier Macmillan, London 1980; 317–340
   Google Scholar
• Garcia-Barcelo M, Chow LY, Chiu HF, Wing YK, Lee DT, Lam KL, Waye MM. Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population. Clinical Chemistry 2000; 46: 18–23
   PubMed Web of Science ®Google Scholar
• Hadidi H, Zahlsen K, Idle JR, Cholerton S. A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food Chemistry and Toxicology 1997; 35: 903–907
   PubMed Web of Science ®Google Scholar
• Hoffmann D, Melikian A, Adams JD, Brunnemann KD, Haley NJ. New aspects of tobacco carcinogenesis. Carcinogens Comprehensive Survey 1985; 8: 239–256
   PubMedGoogle Scholar
• Ismail R, Teh LK. Genetic polymorphism of CYP2D6: Malaysian Indians have the highest frequency for CYP2D6*4 in Asia. European Journal of Clinical Pharmacology 2001; 57(8)617–618
   PubMed Web of Science ®Google Scholar
• Ismail R, Teh LK, Amir J, Alwi Z, Lopez CG. Genetic polymorphism of CYP2D6 in Chinese subjects in Malaysia. Journal of Clinical Pharmacology and Therapy 2003; 28(4)279–284
   PubMed Web of Science ®Google Scholar
• London S, Idle JR, Daly AK, Coetzee GA. Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 1999; 353: 898–899
   PubMed Web of Science ®Google Scholar
• Muthiah YD, Lee WL, The LK, Ong CE, Ismail R. Genetic polymorphisms of CYP2C8 in three Malaysian ethnics: CYP2C8*2 and CYP2C8*3 are found in Malaysian Indians. Journal of Clinical Pharmacy and Therapeutics 2005; 30(5)487–490
   PubMed Web of Science ®Google Scholar
• Nunoya KI, Yokoi T, Kimura K, Inoue K, Kodama T, Funayama M, Nagashima K, Funae Y, Green C, Kinoshita M, Kamataki T. A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502). Pharmacogenetic 1998; 8: 239–249
   PubMedGoogle Scholar
• Oscarson M, Gullsten H, Rautio A, et al. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase. FEBS Letters 1998; 438: 201–205
   PubMed Web of Science ®Google Scholar
• Oscarson M, McLellan RA, Gullsten H, et al. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Letters 1999a; 448: 105–110
   PubMed Web of Science ®Google Scholar
• Oscarson M, McLellan RA, Gullsten H, et al. Identification and characterization of novel polymorphisms in the CYP2A locus: implication for nicotine metabolism. FEBS Letters 1999b; 460: 321–327
   PubMed Web of Science ®Google Scholar
• Patten CJ, Smith TJ, Freisen MJ, Tynes RE, Yang CS, Murphy SE. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N′-nitrosonornicotine α-hydroxylation by human liver microsomes. Carcinogenesis 1997; 18: 1623–1630
   PubMed Web of Science ®Google Scholar
• Pianezza ML, Sellers EM, Tyndale RF. Nicotine metabolism defect reduces smoking. Nature 1998; 393: 750
   PubMed Web of Science ®Google Scholar
• Rautio A, Kraul H, Kojo A, Salmela E, Pelkonen O. Interindividual variability of coumarin 7-hydroxylation in healthy individuals. Pharmacogenetics 1992; 2: 227–233
   PubMedGoogle Scholar
• Sadeque AJM, Fisher MB, Korzekwa KR, Gonzalez FJ, Rettie AE. Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid. Journal of Pharmacology and Experimental Therapy 1997; 283: 672–698
   Web of Science ®Google Scholar
• Schoedel KA, Hoffmann EB, Rao Y, Sellers EM, Tyndale RF. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics 2004; 14: 615–626
   PubMedGoogle Scholar
• Shimada T, Yamazaki H, Guengerich FP. Ethnic-related differences in coumarin 7-hydroxylation activity catalyzed by cytochrome P2402A6 in liver microsomes of Japanese and Caucasians populations. Xenobiotica 1996; 26: 395–403
   PubMed Web of Science ®Google Scholar
• Teh LK, Ismail R, Yusoff R, Hussein A, Isa MN, Rahman AR. Heterogeneity of the CYP2D6 gene among Malays in Malaysia. Journal of Clinical Pharmacology and Therapy 2001; 26(3)205–211
   PubMed Web of Science ®Google Scholar
• Tyndale RF, Sellers EM. Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. Therapeutic Drug Monitoring 2002; 24: 163–171
   PubMed Web of Science ®Google Scholar
• Wang J, Pitarque M, Ingelman-Sundberg M. 3′-UTR polymorphism in the human CYP2A6 gene effects mRNA stability and enzyme expression. Biochemistry and Biophysics Research Communications 2006; 340: 491–497
   PubMed Web of Science ®Google Scholar
• Xu P, Huang SL, Zhu RH, Han XM, Zhou HH. Phenotypic polymorphism of CYP2A6 activity in a Chinese population. European Journal of Clinical Pharmacology 2002; 58: 333–337
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Inui Y, Yun CH, Guengerich FP, Shimada T. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco related nitrosamines in human liver microsomes. Carcinogenesis 1992; 13: 1789–1794
   PubMed Web of Science ®Google Scholar
• Yoshida R, Nakajima M, Watanabe Y, Tack J, Yokoi T. Genetic polymorphism in human CYP2A6 gene causing impaired nicotine metabolism. British Journal of Clinical Pharmacology 2002; 54: 511–517
   PubMed Web of Science ®Google Scholar